Merck refinances €2bn RCF with oversubscribed line
German pharmaceuticals firm Merck has refinanced a €2bn revolver maturing in 2014 with a new facility of the same size.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
